Torrent Pharma's Vizag API Unit Passes USFDA Inspection with Zero Observation
The US Food and Drug Administration (USFDA) has completed the inspection of Torrent Pharma's API manufacturing facility located in Vizag, Andhra Pradesh.
Torrent Pharmaceuticals | 04/08/2025 | By Dineshwori | 181
Torrent Pharma Enters Adult Nutrition Segment with Launch of Shelcal Total
Torrent Pharmaceuticals has announced the expansion of its flagship Shelcal brand into the growing nutrition segment with the launch of a scientifically formulated adult nutrition supplement powder.
Torrent Pharmaceuticals | 24/07/2025 | By Dineshwori | 200
Torrent Pharma to Acquire Controlling Stake in JB Pharma from KKR in INR 25,689 Crore Deal
Torrent Pharmaceuticals has announced plans to acquire a controlling stake in JB Pharma from KKR in an INR 25,689 crore deal, paving the way for a merger that will significantly boost its Indian market position and global expansion strategy.
Torrent Pharmaceuticals | 01/07/2025 | By Mrinmoy Dey | 190
Torrent Pharma Signs Deal with Boehringer Ingelheim to Acquire Three Anti-Diabetes Brands
Empagliflozin is a novel sodium-glucose co-transporter-2 (SGLT-2) inhibitor that is indicated for glycemic control in adults with type 2 diabetes mellitus.
Torrent Pharmaceuticals | 09/12/2024 | By Aishwarya | 372
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy